MATTHEW BOBZIEN: Open Payments
NPI 1962508812 · JAMESTOWN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,838 in 113 payments from 26 companies in 2025. Trend: 2023 $1,629 · 2024 $1,774 · 2025 $1,838
Food & beverage: $1,838
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $467 |
| Lilly USA, LLC | 14 | $218 |
| PFIZER INC. | 13 | $157 |
| Amgen Inc. | 9 | $149 |
| AstraZeneca Pharmaceuticals LP | 4 | $148 |
| Novo Nordisk Inc | 6 | $107 |
| Dexcom, Inc. | 3 | $72 |
| Inspire Medical Systems, Inc. | 3 | $69 |
| Lundbeck LLC | 3 | $53 |
| HARMONY BIOSCIENCES LLC | 1 | $47 |
Products named: MOUNJARO, VRAYLAR, NURTEC ODT, QULIPTA, BREZTRI, UBRELVY, Ozempic, OTEZLA.
Industry payments across IN — which companies pay providers there.
